[Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents].
Akira
A
Fujiki
D000638:Amiodarone / Q000494:pharmacology / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000145:classification* / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology*; D015764:Bepridil / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D011744:Pyrimidinones / Q000494:pharmacology / Q000627:therapeutic use*; D013015:Sotalol / Q000494:pharmacology / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D011744:Pyrimidinones; C076259:nifekalant; D015764:Bepridil; D013015:Sotalol; D000638:Amiodarone